Relationship of fasting total homocysteine, high sensitivity C-reactive protein and features of the metabolic syndrome in Trinidadian subjects

Archives of Physiology and Biochemistry

Volumn 119, Issue 1, 2013, Pages 22-26

  Nayak, B S ^a   Pinto Pereira, L M ^a   Seemungal, T ^b   Davis, G ^a   Teelucksingh, S ^b   Jagessar, A ^a   Legall, G ^a  

^a Department of Preclinical Sciences ^*  (United States)

^b UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

Cardiovascular risk factors; Hs CRP; Metabolic syndrome; Plasma homocysteine

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET RESTRICTION; ETHNOLOGY; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; RISK FACTOR; TRINIDAD AND TOBAGO; WAIST CIRCUMFERENCE;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FASTING; FEMALE; HOMOCYSTEINE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; TRINIDAD AND TOBAGO; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84873353230     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2012.735245     Document Type: Article

References (33)

1. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. (2007). Te burden and costs of low income and middle income countries. Lancet 370:1929-38.
2. Anderson JL, Muhlestein JB, Horne BD, Carlquist JF, Bair TL, Madsen TE, Pearson RR. (2000). Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein with angiographically defned coronary artery disease. Circulation 102:1227-32.
3. Baumann H, Gauldie J. (2000). Te acute phase response. Immuno Today 15:74-80.
4. Björntorp P, Bengtsson C, Blohme G, Jonsson A, Sjostrom L, Tibblin E, Tibblin G, Wilhelmsen L. (1971). Adipose tissue fat cell size and number in relation to metabolism in randomly selected middle-aged men and women. Metabolism 20:927-35.
5. Bostom AG, Silbershatz H, Rosenberg IH, Selhub J, DAgostino RB, Wolf PA, Jacques PF, Wilson PWF. (1999). Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 159:1077-80.
6. Brochu M, Starling RD, Tchernof A, Matthews DE, Garcia-Rubi E, Poehlman ET. (2000). Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women. J Cin Endocrinol Metab 85:2378-84.
7. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfeld JE. (1994). Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 24:1468-74.
8. DeFronzo RA, Ferrannini E. (1991). Insulin resistance: A multifaced syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-94.
9. Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S. (1999). Homocysteine and cardiovascular disease: a critical review of epidemiologic evidence. Ann Intern Med 131:363-75.
10. Fonseca V, Guba SC, Fink LM. (1999). Hyper-homocysteinaemia and the endocrine system: implications for atherosclerosis and thrombosis. Endocr Rev 20:738-59.
11. Fröhlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, Muche R, Brenner H, Koenig W. (2000). Association between C-reactive protein and features of the metabolic syndrome. Diabetes Care 23:1835-39.
12. Grundy SM. (1999). Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 83:25-9F.
13. Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, Fujimoto WY. (2004). Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med 140:992-1000.
14. International Diabetes Federation. Worldwide defnition of metabolic syndrome. Available at: http://www.idf.org/webdata/docs/IDFMetabolic-syndrome- defnition.pdf. Accessed 24 June 2010.
15. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Tuillez. (1995). Nitric oxide is responsible for fow dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91:1314-19.
16. Kannel WB, Wilson PWF, DAgostino RB, Levy D, Belanger AM. (1998). Sudden coronary death in women. Am Heart J 136:205-12.
17. Kuller LH, Tracy RP, Shaten J, Meilahn EN. (1996). Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case control study: Multiple Risk Factor Intervention Trial. Am J Empidemiol 144:537-47.
18. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. (1984). Distribution of adipose tissue and risk of cardiovascular disease and death: 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 289:1257-61.
19. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G. (1984). Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J 288:1401-4.
20. Lentz SR. (1998). Mechanisms of thrombosis in hyperhomocysteinemia. Curr Opin Hematol 5:343-49.
21. PAHO. (2006). Report of the Caribbean Commission of Health and Development 2006.
22. Pasceri V, Willerson JT, Yeh ETH. (2000). Direct proinfammatory efect of C-reactive protein on human endothelial cells. Circulation 102:2165-68.
23. Raji A, Seely EW, Arky RA, Simonson DC (2001). Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 86:5366-71.
24. Reaven GM, Lithell H, Landsberg L. (1996). Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 334:374-81
25. Rendell M, Hulthen UL, Tornquist C, Groop L, Mattiasson I. (2001). Relationship between abdominal fat compartments and glucose and lipid metabolism in early postmenopausal women. J Clin Endocrinol Metab 86:744-9.
26. Ridker PM, Buring JE, Cook NR, Rifai N. (2003). C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107(3):391-7.
27. Saad MF, Rewers M, Selby J, Howard G, Jinagouda S, Fahmi S, Zaccaro D, Bergman RN, Savage PJ, Hafner SM. (2004). Insulin resistance and hypertension: Te Insulin Resistance Atherosclerosis study. Hypertension 43:1324-31.
28. Sarnak MJ, Levey AS. (2000). Cardiovascular disease and chronic renal disease: A new paradigm. Am J Kidney Dis 35(Suppl. 4):S117-31.
29. Tchoukalova YD, Koutsari C, Karpyak MV, Votruba SB, Wendland E, Jensen MD. (2008). Subcutaneous adipocyte size and body fat distribution. Am J Clin Nutr 87:56-63.
30. Tizianello A, de Ferrari G, Garibotto G, Gerreri G, Robaudo C. (1980). Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufciency. J Clin Invest 65:1162-72.
31. Ueland PM, Refsum H. (1989). Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease and drug therapy. J Lab Clin 114:473-501.
32. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. (2003). Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-808.
33. Zimmet P, Boyko EJ, Collier GR, de Courten M. (1999). Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players. Ann NY Acad Sci 892:25-44.